Muscle protein synthesis (MPS) is often treated as a proxy for hypertrophy, yet the relationship between acute postprandial MPS elevations and chronic lean mass accrual is more correlational than causal. A systematic review and meta-analysis of protein supplementation during resistance exercise training reported a pooled standardized mean difference of 0.30 (95% CI 0.12–0.48) for fat-free mass gains in healthy adults, translating to a small but non-trivial effect. The analysis, which included 49 randomized controlled trials with 1863 participants, found that protein supplementation augmented RET-induced gains in one-repetition maximum strength as well, with a similar effect size of 0.31 (95% CI 0.14–0.49). These population-level estimates, however, mask considerable heterogeneity driven by training status, age, and baseline protein intake.

Protein Dose and Lean Mass Outcomes

The dose-response curve for protein intake and lean body mass appears to plateau beyond 1.6 g/kg/day in meta-regression, though confidence intervals allow for marginal benefits at higher intakes in resistance-trained individuals. A separate meta-analysis focusing on protein interventions without concomitant exercise training found limited evidence for lean mass improvements in healthy non-obese adults, suggesting that protein alone is a weak anabolic stimulus in the absence of mechanical loading. In older adults with acute or chronic conditions, protein and amino acid supplementation produced a small but significant preservation of fat-free mass (mean difference 0.34 kg, 95% CI 0.06–0.62), yet effects on muscle strength and physical function were inconsistent. The heterogeneity in these findings underscores a principle often lost in translation: MPS is necessary but not sufficient for functional adaptation.

Omega-3 Fatty Acids and MPS in Aging

The search for nutritional adjuncts that amplify MPS has turned toward omega-3 polyunsaturated fatty acids (n-3 PUFAs), particularly in older adults where anabolic resistance blunts the MPS response to protein feeding. A systematic review and meta-analysis of eight studies found that n-3 PUFA ingestion increased MPS rates in older adults, with a pooled effect size of 0.48 (95% CI 0.06–0.90). The effect was more pronounced in studies using higher doses (>2 g/day) and longer intervention periods, though the meta-analysis noted that publication bias could not be excluded. Mechanistically, n-3 PUFAs may enhance MPS by incorporating into skeletal muscle phospholipid membranes, improving insulin sensitivity, and attenuating the inflammatory signaling that suppresses anabolic pathways. However, the clinical relevance remains uncertain, as changes in MPS did not consistently translate to improvements in muscle mass or strength across the included trials.

Proteomic Insights and Population Specificity

Proteomic analyses add a layer of complexity by revealing that exercise training and metabolic disease induce distinct protein expression signatures in skeletal muscle. A systematic review and meta-analysis of proteomics literature identified 13 proteins differentially expressed in response to exercise training versus obesity/type 2 diabetes, including myosin heavy chain isoforms (MYH1, MYH2) and metabolic enzymes (PYGM, G3P). These findings suggest that MPS is not a monolithic process but a collection of signaling events that diverge based on physiological context. For instance, the upregulation of contractile proteins following resistance training contrasts with the oxidative stress-related protein changes seen in insulin-resistant muscle. Such data caution against extrapolating MPS responses from healthy young populations to older or clinical cohorts, and they highlight the need for proteomic-level phenotyping in future trials.

Practical Application and Caveats

For practitioners, the evidence supports a protein intake of 1.6–2.2 g/kg/day for individuals engaged in regular resistance training, distributed across 3–4 meals with 0.4–0.55 g/kg per meal to maximize MPS. Older adults may benefit from higher per-meal doses (0.6 g/kg) and consideration of n-3 PUFA supplementation, though the effect sizes are modest and individual response varies. The meta-analytic data on protein timing are less robust; total daily intake appears to be a stronger determinant of lean mass gains than peri-workout nutrient timing. A critical caveat is that most MPS studies measure acute fractional synthetic rate over hours, while hypertrophy requires sustained net protein balance over weeks. Thus, MPS data should inform, not dictate, nutritional strategies. Additionally, the meta-analyses reviewed here predominantly include healthy or mildly frail populations, limiting generalizability to clinical sarcopenia or cachexia. The interaction between protein quality (e.g., leucine content, digestibility) and MPS is well-established but was not a focus of these analyses, and it may account for some residual heterogeneity.

For personal medical concerns, please consult a qualified physician.

Protein Synthesis: Parsing the Evidence on Intake, Timing, and Augmentation

Protein Dose and Lean Mass Outcomes

Omega-3 Fatty Acids and MPS in Aging

Proteomic Insights and Population Specificity

Practical Application and Caveats

References

Related Articles

Periodization Evidence: A Reappraisal of Meta-Analytic Findings

Sleep and Training: The Evidence on Resistance Exercise and Sleep Outcomes

Periodization Research: A Critical Reappraisal of the Evidence